Shupp Alison, Casimiro Mathew C, Pestell Richard G
Departments of Cancer Biology, Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA.
Pennsylvania Cancer and Regenerative Medicine Research Center, Baruch S Blumberg Institute, Doylestown, PA, USA.
Oncotarget. 2017 Mar 7;8(10):17373-17382. doi: 10.18632/oncotarget.14538.
Cyclin dependent kinases are proline-directed serine/threonine protein kinases that are traditionally activated upon association with a regulatory subunit. For most CDKs, activation by a cyclin occurs through association and phosphorylation of the CDK's T-loop. CDK5 is unusual because it is not typically activated upon binding with a cyclin and does not require T-loop phosphorylation for activation, even though it has high amino acid sequence homology with other CDKs. While it was previously thought that CDK5 only interacted with p35 or p39 and their cleaved counterparts, Recent evidence suggests that CDK5 can interact with certain cylins, amongst other proteins, which modulate CDK5 activity levels. This review discusses recent findings of molecular interactions that regulate CDK5 activity and CDK5 associated pathways that are implicated in various diseases. Also covered herein is the growing body of evidence for CDK5 in contributing to the onset and progression of tumorigenesis.
细胞周期蛋白依赖性激酶是脯氨酸定向的丝氨酸/苏氨酸蛋白激酶,传统上与调节亚基结合后被激活。对于大多数细胞周期蛋白依赖性激酶(CDK)而言,细胞周期蛋白的激活是通过与CDK的T环结合并使其磷酸化来实现的。CDK5不同寻常,因为它通常不会在与细胞周期蛋白结合时被激活,并且激活也不需要T环磷酸化,尽管它与其他CDK具有高度的氨基酸序列同源性。虽然之前认为CDK5只与p35或p39及其裂解产物相互作用,但最近的证据表明,CDK5可以与某些细胞周期蛋白以及其他蛋白质相互作用,这些蛋白质可调节CDK5的活性水平。本综述讨论了调节CDK5活性的分子相互作用以及与各种疾病相关的CDK5相关途径的最新研究结果。本文还涵盖了越来越多的证据表明CDK5在肿瘤发生的起始和进展中发挥作用。